CONSOLIDATED STATEMENT OF FINANCIAL POSITION for the year ended 31 March 2025





31 March 2025

31 March 2024


note

£

£

TOTAL ASSETS




Non-current assets




Plant and equipment

7

480

640



480

640

Current assets




Inventory

11

1,310,069

775,374

Investment properties

8

0

0

Trade and other receivables

9

65,350

79,576

Cash and cash equivalents

10

27,429

8,906



1,402,848

863,856

Total assets


1,403,328

864,496





EQUITIES & LIABILITIES




Current Liabilities




Trade and other payables

12

348,099

285,614

Borrowings

13

966,250

0



1,314,349

285,614





Non-current liabilities




Deferred tax

5

0

0

Borrowings

13

3,226,541

3,415,728



3,226,541

3,415,728

Total liabilities


4,540,890

3,701,342





Net liabilities


(3,137,562)

(2,836,846)









Called up share

14

3,260,025

3,237,400

Share premium


4,213,165

4,136,240

Reverse acquisition reserve


(2,817,633)

(2,817,633)

Loan note equity reserve

14 & 16

0

0

Capital contribution reserve

17

400,147

400,147

Profit & loss account


(8,193,266)

(7,793,000)

Total Equity


(3,137,562)

(2,836,846)

Total Equity & Liabilities


1,403,328

864,496

These financial statements were approved by the Board of Directors and authorised for issue on 21 October 2025 and are signed on its behalf by:


P Treadaway: ………………………………………. G Thorneycroft: …………………………………………


The notes are an integral part of these consolidated financial statements.

Annual report & consolidated financial statements 2025